Codexis (CDXS)

Codexis (CDXS) Stock Price & Analysis


CDXS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.45 - $6.98
Previous Close$2.27
Average Volume (3M)848.78K
Market Cap
Enterprise Value$96.21M
Total Cash (Recent Filing)$74.60M
Total Debt (Recent Filing)$19.98M
Price to Earnings (P/E)-1.9
Feb 22, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding69,830,199
10 Day Avg. Volume769,145
30 Day Avg. Volume848,777
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)1.69
Price to Sales (P/S)1.14
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.30
Enterprise Value/Gross Profit0.96
Enterprise Value/Ebitda-1.34
Price Target Upside208.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4



Ownership Overview

10.79% Insiders
21.98% Mutual Funds
37.95% Other Institutional Investors
29.29% Public Companies and Individual Investors


What was Codexis’s price range in the past 12 months?
Codexis lowest stock price was $1.45 and its highest was $6.98 in the past 12 months.
    What is Codexis’s market cap?
    Currently, no data Available
    When is Codexis’s upcoming earnings report date?
    Codexis’s upcoming earnings report date is Feb 22, 2024 which is in 85 days.
      How were Codexis’s earnings last quarter?
      Codexis released its earnings results on Nov 02, 2023. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of -$0.324 by -$0.176.
        Is Codexis overvalued?
        According to Wall Street analysts Codexis’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Codexis pay dividends?
          Codexis does not currently pay dividends.
          What is Codexis’s EPS estimate?
          Codexis’s EPS estimate is -$0.16.
            How many shares outstanding does Codexis have?
            Codexis has 69,830,200 shares outstanding.
              What happened to Codexis’s price movement after its last earnings report?
              Codexis reported an EPS of -$0.5 in its last earnings report, missing expectations of -$0.324. Following the earnings report the stock price went up 7.222%.
                Which hedge fund is a major shareholder of Codexis?
                Among the largest hedge funds holding Codexis’s share is Graham Capital Management, L.P.. It holds Codexis’s shares valued at 29K.


                  Company Description


                  Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.


                  Top 5 ETFs holding CDXS

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Avantis U.S. Equity ETF
                  Up to five ETFs with an Outperform Smart Score that hold CDXS. The ETFs are listed according to market value of CDXS within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Meiragtx Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis